Page last updated: 2024-12-08
pipethiaden
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
pipethiaden: used in treatment of migraine; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 197209 |
CHEMBL ID | 3634677 |
MeSH ID | M0131823 |
Synonyms (14)
Synonym |
---|
4m164i6e36 , |
pipethiadene |
piperidine, 1-methyl-4-thieno(2,3-c)(2)benzothiepin-4(9h)-ylidene- |
unii-4m164i6e36 |
1-methyl-4-thieno(2,3-c)(2)-benzothiepin-4(9h)-ylidene piperidine |
15053-99-3 |
pipethiaden |
1-methyl-4-(5h-thieno[2,3-c][2]benzothiepin-10-ylidene)piperidine |
pipethiadene [who-dd] |
piperidine, 1-methyl-4-(thieno(2,3-c)(2)benzothiepin-4(9h)-ylidene)- |
CHEMBL3634677 |
DTXSID70164567 |
4-(1-methyl-4-piperidylidene)-4,9-dihydrothieno(2,3-c)-2-benzothiepin |
Q27260070 |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" Some pharmacokinetic parameters (e." | ( Pharmacokinetics of 3H-pipethiaden after single oral and intravenous administration in rats. Franc, Z; Lapka, R; Smolik, S, 1985) | 0.58 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1256198 | Inhibition of Legionella pneumophila recombinant PAH assessed as tyrosine production by DSF assay using 1 mM L-Phe as substrate and 200 uM BH4 as cofactor | 2015 | Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21 | Discovery of a Specific Inhibitor of Pyomelanin Synthesis in Legionella pneumophila. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.24) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |